Sickle Cell Disease
Showing NaN - NaN of 72
Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)
Recruiting
- Sickle Cell Disease
- NDec - oral decitabine-tetrahydrouridine
- +2 more
-
Oakland, California
- +39 more
Jan 24, 2023
Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)
Recruiting
- Sickle Cell Disease
- VIT-2763 120 mg
- +4 more
-
Birmingham, Alabama
- +12 more
Jan 20, 2023
Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA
Recruiting
- Sickle Cell Disease
- Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
-
Los Angeles, California
- +8 more
Jan 10, 2023
Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)
Recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- EDIT-301
-
Oakland, California
- +18 more
Jan 10, 2023
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Sickle Cell Disease Treated With Ex Vivo Gene Therapy
Enrolling by invitation
- Sickle Cell Disease
- Safety and efficacy assessments
-
Birmingham, Alabama
- +11 more
Oct 31, 2022
Sickle Cell Disease, Genetic Disease, Hematologic Diseases Trial in United States (Electronic Health Record (EHR) Embedded
Completed
- Sickle Cell Disease
- +3 more
- Electronic Health Record (EHR) Embedded Individualized Pain Plan (IPP)
-
Oakland, California
- +7 more
Oct 26, 2022
Sickle Cell Disease Trial in Netherlands, United Kingdom, United States (CSL889)
Recruiting
- Sickle Cell Disease
- CSL889
-
Chicago, Illinois
- +12 more
Oct 11, 2022
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)
Enrolling by invitation
- Sickle Cell Disease
-
Washington, District of Columbia
- +10 more
Sep 27, 2022
Sickle Cell Disease Trial in United States (CD34 selected T-cell depleted allogeneic SCT)
Active, not recruiting
- Sickle Cell Disease
- CD34 selected T-cell depleted allogeneic SCT
-
Los Angeles, California
- +5 more
Sep 27, 2022
Sickle Cell Disease Trial in United States (InCharge Health mobile application, HU Toolbox mobile application)
Completed
- Sickle Cell Disease
- InCharge Health mobile application
- HU Toolbox mobile application
-
Augusta, Georgia
- +6 more
Sep 26, 2022
Sickle Cell Disease Trial in France, United Kingdom, United States (Red Blood Cell, Standard of care)
Recruiting
- Sickle Cell Disease
- Red Blood Cell
- Standard of care
-
Tuscaloosa, Alabama
- +19 more
Aug 23, 2022
The Predictive Capacity of Machine Learning Models for
Recruiting
- Sickle Cell Disease
- Kidney Diseases, Chronic
- Biospecimen/DNA collection and analysis
-
Chicago, Illinois
- +2 more
Jul 14, 2022
Sickle Cell Disease, Sickle Cell Nephropathy Trial in Chicago (Voxelotor)
Recruiting
- Sickle Cell Disease
- Sickle Cell Nephropathy
-
Chicago, IllinoisUniversity of Illinois
Jun 16, 2022
Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)
Recruiting
- Sickle Cell Disease
- αβ+ T-cell depletion with Miltenyi CliniMACS system
-
Chicago, IllinoisThe University of Chicago
May 13, 2022
Sickle Cell Disease Trial in Chicago (Nicotinamide)
Recruiting
- Sickle Cell Disease
-
Chicago, IllinoisUniversity of Illinois at Chicago College of Medicine
Mar 21, 2022
Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)
Recruiting
- Sickle Cell Disease
- +3 more
- MED-Go App
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Mar 7, 2022
Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)
Recruiting
- Sickle Cell Disease
- Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
-
Washington, District of Columbia
- +5 more
Mar 2, 2022